Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 4,643 shares at $19.34 ($88K) on 2023-06-07, disclosed to the SEC on 2023-06-08.
Scheduled sale ($88k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.61 | 2,143 | $40K | 45.2% |
| 2 | $19.34 | 2,500 | $48K | 54.8% |
| Total | $19.00 avg | 4,643 | $88K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |